Therefore, the modulation of HO-1 by SFN activation may contribute to hepatic protection, reinforcing SFN as a potential hepatoprotective agent with dual actions: elimination of HCV infection and prevention of HCC development. Here, HMOX1 is linked to hepatocellular carcinoma.